Trial intelligence / Profile preview

Intra-articular BT-A vs Steroid for Hemiplegic Shoulder Pain

NCT01473277Phase 2Unknown

Sponsor
Fondazione Giglio
Start
Jan 2012
Primary completion
Jun 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of botulinum toxin type A in hemiplegic shoulder pain (PHS), sponsored by Fondazione Giglio. Status: unknown.

02

Drugs

botulinum toxin type A
03

Conditions

hemiplegic shoulder pain (PHS)

Beyond the preview

Go deeper on NCT01473277.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01473277.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call